Liva Healthcare genopslog dette
Great to work on this white paper with the Liva Healthcare team 👇 Liva are behind some of the NHS and industry's most well used digital therapeutics (DTx), notably in diabetes, weight loss and cardiometabolic conditions. DTx sit right at the heart of the three 'shifts' DHSC are targeting in the 10-year plan: analogue > digital 📲 treatment > prevention 🏃♂️ hospital > community 🏘 Ben Lewis Sian Jarvis, CB, FRCGP(H) Stephen Hankinson
Liva Healthcare’s white paper on digital therapeutics is now live! The UK government’s 2024 conference now underway, and healthcare is top of the agenda. With reports like Lord Darzi’s recent NHS Review emphasising the urgency of transforming our healthcare system, one thing is clear: innovation is no longer a choice - it's a necessity. At Liva Healthcare, we’ve been at the forefront of this transformation, using Digital Therapeutics (DTx) to change how chronic diseases like type 2 diabetes, heart disease, and obesity are managed. Our latest white paper, "A White Paper on Digital Therapeutics", explores how DTx can: 🔸 Improve patient outcomes with personalised, real-time care 🔸Reduce the burden on the NHS and healthcare systems globally 🔸 Provide life sciences companies with critical insights for research and development In a world where chronic conditions account for 70% of global deaths, the time to act is now. Discover how DTx can help reshape healthcare for the better. 👉 Download the white paper and see how we're pioneering a digital-first approach to revolutionise healthcare: https://lnkd.in/evNXJVAB